PKM2 uses control of HuR localization to regulate p27 and cell cycle progression in human glioblastoma cells
Mukherjee, Joydeep, Ohba, Shigeo, See, Wendy L., Phillips, Joanna J., Molinaro, Annette M., Pieper, Russell O.
Published in International journal of cancer (01.07.2016)
Published in International journal of cancer (01.07.2016)
Get full text
Journal Article
p27 deficiency is associated with migration defects in PDGF-expressing gliomas in vivo
See, Wendy L., Heinberg, Adina R., Holland, Eric C., Resh, Marilyn D.
Published in Cell cycle (Georgetown, Tex.) (15.04.2010)
Published in Cell cycle (Georgetown, Tex.) (15.04.2010)
Get full text
Journal Article
Enasidenib, an inhibitor of mutant IDH2 proteins, induces durable remissions in older patients with newly diagnosed acute myeloid leukemia
Pollyea, Daniel A., Tallman, Martin S., de Botton, Stéphane, Kantarjian, Hagop M., Collins, Robert, Stein, Anthony S., Frattini, Mark G., Xu, Qiang, Tosolini, Alessandra, See, Wendy L., MacBeth, Kyle J., Agresta, Samuel V., Attar, Eyal C., DiNardo, Courtney D., Stein, Eytan M.
Published in Leukemia (01.11.2019)
Published in Leukemia (01.11.2019)
Get full text
Journal Article
Prognostic impact of NPM1 and FLT3 mutations in patients with AML in first remission treated with oral azacitidine
Döhner, Hartmut, Wei, Andrew H., Roboz, Gail J., Montesinos, Pau, Thol, Felicitas R., Ravandi, Farhad, Dombret, Hervé, Porkka, Kimmo, Sandhu, Irwindeep, Skikne, Barry, See, Wendy L., Ugidos, Manuel, Risueño, Alberto, Chan, Esther T., Thakurta, Anjan, Beach, C.L., Lopes de Menezes, Daniel
Published in Blood (13.10.2022)
Published in Blood (13.10.2022)
Get full text
Journal Article
Survival outcomes in patients with acute myeloid leukaemia who received subsequent therapy for relapse in QUAZAR AML-001
Ravandi, Farhad, Döhner, Hartmut, Wei, Andrew H, Montesinos, Pau, Pfeilstöcker, Michael, Papayannidis, Cristina, Lai, Yinzhi, Wang, Kefeng, See, Wendy L, de Menezes, Daniel Lopes, Petrlik, Erica, Prebet, Thomas, Roboz, Gail J
Published in British journal of haematology (01.03.2024)
Published in British journal of haematology (01.03.2024)
Get full text
Journal Article
Oral azacitidine modulates the bone marrow microenvironment in patients with acute myeloid leukaemia in remission: A subanalysis from the QUAZAR AML‐001 trial
Menezes, Daniel L., See, Wendy L., Risueño, Alberto, Tsai, Kao Tai, Lee, Jae K., Ma, Johnny, Khan, Rida, Prebet, Thomas, Skikne, Barry, Beach, C. L., Thakurta, Anjan, Gandhi, Anita
Published in British journal of haematology (01.06.2023)
Published in British journal of haematology (01.06.2023)
Get full text
Journal Article
Combination of azacitidine and enasidenib enhances leukemic cell differentiation and cooperatively hypomethylates DNA
MacBeth, Kyle J., Chopra, Vivek S., Tang, Lin, Zheng, Bing, Avanzino, Brian, See, Wendy L., Schwickart, Martin, Figueroa, Maria E., Quek, Lynn, DiMartino, Jorge F.
Published in Experimental hematology (01.06.2021)
Published in Experimental hematology (01.06.2021)
Get full text
Journal Article
Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AML
Risueño, Alberto, See, Wendy L., Bluemmert, Iryna, de Botton, Stéphane, DiNardo, Courtney D., Fathi, Amir T., Schuh, Andre C., Montesinos, Pau, Vyas, Paresh, Prebet, Thomas, Gandhi, Anita, Hasan, Maroof
Published in Leukemia research (01.05.2024)
Published in Leukemia research (01.05.2024)
Get full text
Journal Article
Enasidenib in patients with mutant IDH2 myelodysplastic syndromes: a phase 1 subgroup analysis of the multicentre, AG221-C-001 trial
Stein, Eytan M, Fathi, Amir T, DiNardo, Courtney D, Pollyea, Daniel A, Roboz, Gail J, Collins, Robert, Sekeres, Mikkael A, Stone, Richard M, Attar, Eyal C, Frattini, Mark G, Tosolini, Alessandra, Xu, Qiang, See, Wendy L, MacBeth, Kyle J, de Botton, Stéphane, Tallman, Martin S, Kantarjian, Hagop M
Published in The Lancet. Haematology (01.04.2020)
Published in The Lancet. Haematology (01.04.2020)
Get more information
Journal Article
Long‐term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo‐controlled, phase 3 QUAZAR AML‐001 trial
Wei, Andrew H., Döhner, Hartmut, Sayar, Hamid, Ravandi, Farhad, Montesinos, Pau, Dombret, Hervé, Selleslag, Dominik, Porkka, Kimmo, Jang, Jun‐Ho, Skikne, Barry, Beach, C. L., Prebet, Thomas, Zhang, George, Risueño, Alberto, Ugidos, Manuel, See, Wendy L., Menezes, Daniel, Roboz, Gail J.
Published in American journal of hematology (01.04.2023)
Published in American journal of hematology (01.04.2023)
Get full text
Journal Article
P459: DISEASE MONITORING OF NPM1‐MUTANT (MUT) ACUTE MYELOID LEUKEMIA (AML) USING MEASURABLE RESIDUAL DISEASE (MRD) ASSESSMENTS DURING ORAL AZACITIDINE (ORAL‐AZA) TREATMENT (TX): A QUAZAR AML‐001 SUBANALYSIS
Lopes De Menezes, Daniel, Roboz, Gail, Döhner, Hartmut, Wei, Andrew, Teresa Voso, Maria, Schuh, Andre, See, Wendy L., Ugidos, Manuel, Amzallag, Arnaud, Risueño, Alberto, H. Eng, Kevin, Nvs Suragani, Rajasekhar, Skikne, Barry, Beach, CL, Prebet, Thomas, Gandhi, Anita
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
P411: LONGITUDINAL CHARACTERIZATION OF MOLECULAR VARIANTS AT REMISSION AND RELAPSE: SUBANALYSIS OF THE QUAZAR AML‐001 TRIAL
Lopes De Menezes, Daniel, Wei, Andrew, Döhner, Hartmut, Roboz, Gail, Teresa Voso, Maria, Schuh, Andre, See, Wendy L., Ugidos, Manuel, Amzallag, Arnaud, Risueño, Alberto, Kyriakopoulos, Charalampos, Nvs Suragani, Rajasekhar, Skikne, Barry, Beach, CL, Prebet, Thomas, Gandhi, Anita
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Molecular Features Associated with Response to Combination Therapy with Enasidenib (ENA) Plus Azacitidine (AZA) in Newly Diagnosed IDH2-Mutated Acute Myeloid Leukemia (AML)
Risueño, Alberto, See, Wendy L., DiNardo, Courtney D., Döhner, Hartmut, Stein, Eytan, Fathi, Amir T., Vyas, Paresh, Quek, Lynn, Prebet, Thomas, Gandhi, Anita K., Hasan, Maroof
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Abstract 505: Oral azacitidine modulates the immune microenvironment in acute myeloid leukemia (AML) patients in remission: A subanalysis from the QUAZAR AML-001 Trial
Menezes, Daniel L., See, Wendy L., Risueno, Alberto, Ma, Jianglin, La Torre, Ignazia, Skikne, Barry, Beach, CL, Kumar, Keshava, Thakurta, Anjan
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article
Clonal Dynamics of Gene Mutations during Oral Azacitidine Maintenance Therapy in Patients with Acute Myeloid Leukemia (AML): Outcomes from the QUAZAR AML-001 Trial
Lopes De Menezes, Daniel, Guerrero, Manuel Ugidos, Amzallag, Arnaud, See, Wendy L., Risueno, Alberto, Kyriakopoulos, Charalampos, Suragani, Rajasekhar N.V.S., Skikne, Barry S., Beach, C.L., Prebet, Thomas, Voso, Maria Teresa, Schuh, Andre C., Roboz, Gail J., Döhner, Hartmut, Wei, Andrew H., Gandhi, Anita K.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Prognostic Impact of NPM1 and FLT3 Mutations at Diagnosis and Presence of Measurable Residual Disease (MRD) after Intensive Chemotherapy (IC) for Patients with Acute Myeloid Leukemia (AML) in Remission: Outcomes from the QUAZAR AML-001 Trial of Oral Azacitidine (Oral-AZA) Maintenance
Döhner, Hartmut, Wei, Andrew H., Roboz, Gail J., Montesinos, Pau, Thol, Felicitas R, Ravandi, Farhad, Dombret, Hervé, Porkka, Kimmo, Sandhu, Irwindeep, Skikne, Barry, See, Wendy L., Ugidos, Manuel, Risueño, Alberto, Chan, Esther, Thakurta, Anjan, Beach, C.L., Lopes de Menezes, Daniel
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Overall survival by IDH2 mutant allele (R140 or R172) in patients with late-stage mutant- IDH2 relapsed or refractory acute myeloid leukemia treated with enasidenib or conventional care regimens in the phase 3 IDHENTIFY trial
De Botton, Stéphane, Risueño, Alberto, Schuh, Andre C., Lowenberg, Bob, Kim, Hee-Je, Vyas, Paresh, Wei, Andrew H., Stein, Eytan M., Dohner, Hartmut, Fathi, Amir Tahmasb, Dinardo, Courtney Denton, Martin Regueira, Patricia, Taningco, Lilia, Bluemmert, Iryna, Yu, Xin, See, Wendy L., Hasan, Maroof
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
CC-486 Mechanism Imparted By Extended Exposure of Azacitidine Upregulates Myeloid Differentiation Markers and Induces Cell Death in AML Cells
Dunshee, Diana R., Dai, Yumin, Jang, Jessica C., Risueño, Alberto, Jeyaraju, Danny V, Hagner, Patrick, See, Wendy L., MacBeth, Kyle, Wang, Xiaomin, La Torre, Ignazia, Skikne, Barry, Beach, C.L., Kumar, Keshava, Thakurta, Anjan, Lopes de Menezes, Daniel
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article